Public policy and prospects of pharmaceutical MSMES: A study with special reference to Dehradunn, Uttrakhand
By: Choudhary, Priyanka and Singh, Vijay Kumar
.
Material type: 
BookPublisher: Bihar Journal of Public Administration Description: 19(2), Jul-Dec, 2022: p.236-247.Subject(s): MSMEs, Atmanirbhar Bharat, PLI schemes, Pharmaceuticals, Uttrakhand
In:
Bihar Journal of Public AdministrationSummary: Micro, Small and Medium Enterprises (MSMEs) are the major contributors to the GDP of India and among them the MSMEs involved in pharmaceutical industry are the most viable enterprises. It is indeed a bonanza for developing economies like India. But these MSMEs were the worst sufferers during the Covid-19 pandemic. Considering the significant contribution of MSMEs to the country’s overall economic growth, the government has announced a slew of measures under ‘Atmanirbhar Bharat’ to improve their productivity and sustainability to cope up the losses. One such initiative of the government is the Production Linked Incentive Scheme (PLI), which has been launched to incentivize the global and domestic players to enhance investment and production of drugs and high-value products in bulk. Thus, the present paper is an attempt to analyze and identify the issues and challenges in the pharmaceutical MSME sector with special reference to Dehradun, Uttarakhand, all in the context of public policies like Atmanirbhar Bharat and PLI schemes.- Reproduced
| Item type | Current location | Call number | Vol info | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Articles
|
Indian Institute of Public Administration | 19(2), Jul-Dec, 2022: p.236-247 | Available | AR128664 |
Micro, Small and Medium Enterprises (MSMEs) are the major contributors to the GDP of India and among them the MSMEs involved in pharmaceutical industry are the most viable enterprises. It is indeed a bonanza for developing economies like India. But these MSMEs were the worst sufferers during the Covid-19 pandemic. Considering the significant contribution of MSMEs to the country’s overall economic growth, the government has announced a slew of measures under ‘Atmanirbhar Bharat’ to improve their productivity and sustainability to cope up the losses. One such initiative of the government is the Production Linked Incentive Scheme (PLI), which has been launched to incentivize the global and domestic players to enhance investment and production of drugs and high-value products in bulk. Thus, the present paper is an attempt to analyze and identify the issues and challenges in the pharmaceutical MSME sector with special reference to Dehradun, Uttarakhand, all in the context of public policies like Atmanirbhar Bharat and PLI schemes.- Reproduced
There are no comments for this item.